google-site-verification: googlec7193c3de77668c9.html

FDA approves another over-the-counter naloxone nasal spray

[

FDA approves another over-the-counter naloxone nasal spray

The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted to Amphastar Pharmaceuticals.

The 4-mg nasal spray is available for purchase by consumers in pharmacies, convenience stores, and online. The product’s packaging includes five-step pictorial directions, including calling 911 after giving the first dose.

When regaining consciousness after the overdose reversal, some people may experience symptoms such as shaking, sweating, nausea, or feeling angry. The product is safe to use even if it is uncertain whether opioids are the cause of the overdose.

“Reducing opioid overdose deaths is a top priority for the FDA,” Mike Davis M.D., Ph.D., from the FDA Center for Drug Evaluation and Research, said in a statement. “Today’s approval of an additional over-the-counter naloxone nasal spray helps broaden access and offers an additional option for consumers. Empowering people without medical training to take immediate action with these products has been proven to save lives.”

Key medical concepts

NaloxoneOpioid Overdose

Who’s behind this story?


Sadie Harley

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries.

Full profile →


Andrew Zinin

Andrew Zinin

Master’s in physics with research experience. Long-time science news enthusiast. Plays key role in Science X’s editorial success.

Full profile →

Copyright © 2026 HealthDay. All rights reserved.

Citation:
FDA approves another over-the-counter naloxone nasal spray (2026, June 19)
retrieved 19 June 2026
from https://medicalxpress.com/news/2026-06-fda-counter-naloxone-nasal-spray.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.




Source link

Advertisements

See also  Study examines factors that influenced changes in US sterilization policy

Check Also

Metabolite-inspired compounds show promise for ulcerative colitis drug discovery

[ Two structurally modified compounds derived from an anti-inflammatory metabolite demonstrated enhanced anti-inflammatory activity in …

Hidden lymphatic signal amplifier could inform treatments for lymphedema and cancer metastasis

[ Cluster formation of the VEGFR-3/VEGF-C complex and signal amplification When VEGFR-3 was mutated to …

Cellular recycling changes with age, but not how we expected

[ The scientists expanded the number of cell types in their study by transforming skin …

Leave a Reply

Available for Amazon Prime